Partner Headlines - IRWD

  1. Conferences/Events Scheduled for Week of Jun. 9th to Jun. 13th

    Benzinga
  2. Ironwood Pharmaceuticals Announces $150M Proposed Public Offering ...

    Benzinga
  3. Mid-Day Market Update: Dow Tumbles Over 100 Points; Signature ...

    Benzinga
  4. Mid-Morning Market Update: Markets Mixed; Verizon Posts Q4 Profit

    Benzinga
  5. Weekly 3-Year Low Highlight: EXC, RVBD, IRWD, SHOS

    GuruFocus
  6. UPDATE: Cowen & Company Upgraded Ironwood Pharmaceuticals

    Benzinga
  7. Five-Year Lows: Singapore Airlines Limited, Gold Field Ltd., ...

    GuruFocus
  8. Stocks Hitting 52-Week Lows

    Benzinga
  9. Earnings Scheduled For January 15, 2013

    Benzinga
  10. Ironwood Starts Phase I Trial of Anti-Anxiety Drug in US

    Benzinga
  11. Weekly CEO Buys Highlight: GDOT, VOCS, PES, IRWD, ABR

    GuruFocus
  12. Ironwood Pharmaceuticals, Inc. (IRWD) CEO Peter M Hecht buys ...

    GuruFocus
  13. Ironwood and AstraZeneca Announce Linaclotide Collaboration for ...

    Benzinga
  14. Ironwood and Forest Announce FDA Approval of LINZESSTM

    Benzinga
  15. UPDATE: Cantor Fitzgerald Raises PT to $8 on Ironwood Pharmaceuticals; ...

    Benzinga
  16. Biotechs With Upcoming PDUFA Dates

    Benzinga
  17. UPDATE: Wedbush Downgrades Ironwood Pharmaceuticals; Lowers PT

    Benzinga
  18. Bank of America: Zelnorm vs. linaclotide

    Benzinga
  19. Ironwood Pharmaceuticals Announces Exercise of Over-Allotment ...

    Benzinga
  20. From Earlier: Ironwood Pharmaceuticals Prices Public Offering ...

    Benzinga
  21. Ironwood Pharmaceuticals Announces Proposed Public Offering of ...

    Benzinga
  22. Ironwood Pharmaceuticals and Bionomics Announce Collaboration, ...

    Benzinga
  23. European Patent Office Upholds Synergy Pharmaceuticals' Grant ...

    Benzinga
Trading Center